| Developers: | Synthesis Kurgan society of medications and products |
| Date of the premiere of the system: | 2020/07/31 |
Paratsitolgin - medicine, available at the price, with dual directional effect against pain. Does not enter VED, it is released without recipe of the doctor, but before application it is necessary to consult with the specialist.
2020: Obtaining registration certificate
JSC Sintez announced on July 31, 2020 obtaining the registration certificate and start in production of medicine of dual action from muscular, tooth, head and articulate pain of Paratsitolgin. The first 145 thousands packages will appear on counters of 25 pharmacy chains (Pharmperspektiva, Vit, "The planet of health", "Gorzdrav", "36.6", Pharmlend, Zhivika (Yekaterinburg), Asna, etc.) in August, 2020.
 | Their combination strengthens action of each other and increases efficiency of Paratsitolgin by 1.5 times in comparison with monomedicines. Besides, in structure there is no caffeine that allows to avoid negative impact on a cardiovascular system at acceptance, – the President of JSC Sintez Rustem Muratov tells. – Medicine has good potential in retail market. We expect that in the next few years the market share of Paratsitolgin in a segment of analgetics will make not less than 3.5% in rubles". Until the end of 2020 JSC Sintez is going to produce more than 400 thousands packages of Paratsitolgin. |  |
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |